New study aims to predict breast cancer treatment success before it starts
NCT ID NCT07570524
First seen May 15, 2026 · Last updated May 16, 2026 · Updated 1 time
Summary
This study will look at immune cells and genetic markers in tumors and blood from 200 women with early triple-negative breast cancer. The goal is to find clues that can tell doctors which patients will have a complete response to immunochemotherapy and which will not. This could help personalize treatment in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRIPLE NEGATIVE BREAST CANCER (TNBC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre Eugène Marquis
Rennes, 35000, France
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.